These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37001195)

  • 41. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
    Lam K; Schwartz L; Batisti J; Iyer KR
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Is there life after teduglutide?].
    Martínez Martínez AL; Calles Romero LA; Etxeberría Martín E; Monasterio Jiménez O; Zabalegui Eguinoa A; Paja Fano M; Monzón Mendiolea A; Cadenas González A; Cabriada Nuno JL; Iglesias Hernández NC
    Nutr Hosp; 2020 Jul; 34(3):631-635. PubMed ID: 32406744
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hernia enlargement and pancreatitis in a patient with short bowel syndrome treated with teduglutide.
    Conejo I; Mas-Malagarriga N; Riera P; Cardenete J; Puig-Piña R; Rodríguez Blanco M; De Pourcq JT
    Nutr Hosp; 2022 Feb; 39(1):230-232. PubMed ID: 34903028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety Findings in Pediatric Patients During Long-Term Treatment With Teduglutide for Short-Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies.
    Hill S; Carter BA; Cohran V; Horslen S; Kaufman SS; Kocoshis SA; Mercer DF; Merritt RJ; Pakarinen MP; Protheroe S; Thompson JF; Vanderpool CPB; Venick RS; Wales PW; Smith SE; Yoon M; Grimm AA
    JPEN J Parenter Enteral Nutr; 2021 Sep; 45(7):1456-1465. PubMed ID: 33305440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
    Wales PW; Hill S; Robinson I; Raphael BP; Matthews C; Cohran V; Carter B; Venick R; Kocoshis S
    J Pediatr Gastroenterol Nutr; 2024 Jun; ():. PubMed ID: 38873891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term Effects of Teduglutide on Intestinal Mucosa in a Patient With Crohn's Disease and Short Bowel Syndrome: Clinical, Endoscopic and Histological Data Compared.
    Borghini R; Villanacci V; Oberti A; Caronna R; Trecca A
    Inflamm Bowel Dis; 2021 Nov; 27(12):e152-e153. PubMed ID: 34255043
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.
    Fifi A; Raphael BP; Terreri B; Uddin S; Kaufman SS
    J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):666-671. PubMed ID: 37889619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort.
    Pironi L; Sasdelli AS; Venerito FM; Musio A; Pazzeschi C; Guidetti M
    Clin Nutr; 2021 Jun; 40(6):4065-4074. PubMed ID: 33637328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unexpected upper gastrointestinal polyps in patients with short bowel syndrome treated with teduglutide: need for close monitoring.
    de Dreuille B; Cazals-Hatem D; Ronot M; Theou-Anton N; Dermine S; Le Beyec-Le Bihan J; Billiauws L; Le Gall M; Bado A; Joly F
    Am J Clin Nutr; 2023 Jun; 117(6):1143-1151. PubMed ID: 37270288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short-Bowel Syndrome: A Review of Recent Literature.
    Pironi L
    JPEN J Parenter Enteral Nutr; 2020 Aug; 44(6):968-978. PubMed ID: 31802516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.
    Armstrong D; Forbes A; Jeppesen PB; Lee HM; Nagy P; Seidner DL
    Clin Nutr; 2020 Jun; 39(6):1774-1777. PubMed ID: 31522784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome.
    Carter BA; Cohran VC; Cole CR; Corkins MR; Dimmitt RA; Duggan C; Hill S; Horslen S; Lim JD; Mercer DF; Merritt RJ; Nichol PF; Sigurdsson L; Teitelbaum DH; Thompson J; Vanderpool C; Vaughan JF; Li B; Youssef NN; Venick RS; Kocoshis SA
    J Pediatr; 2017 Feb; 181():102-111.e5. PubMed ID: 27855998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome.
    Marier JF; Jomphe C; Peyret T; Wang Y
    Clin Transl Sci; 2021 Nov; 14(6):2497-2509. PubMed ID: 34402197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Teduglutide-induced acute gastric mucosal necrosis in short bowel syndrome with hepatorenal failure: Case report.
    Takahashi T; Maejima T; Miyazaki D; Fukahori S; Hagiwara M
    Int J Surg Case Rep; 2024 Apr; 117():109524. PubMed ID: 38493615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-utility analysis of teduglutide compared to standard care in weaning parenteral nutrition support in children with short bowel syndrome.
    Gattini D; Belza C; Kraus R; Avitzur Y; Ungar WJ; Wales PW
    Clin Nutr; 2023 Dec; 42(12):2363-2371. PubMed ID: 37862822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
    Tappenden KA; Edelman J; Joelsson B
    J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Teduglutide: a guide to its use in short bowel syndrome.
    McKeage K
    Clin Drug Investig; 2015 May; 35(5):335-40. PubMed ID: 25859983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome.
    Chen KS; Xie J; Tang W; Zhao J; Jeppesen PB; Signorovitch JE
    Ther Clin Risk Manag; 2018; 14():1267-1277. PubMed ID: 30100725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.